{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20030519",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21381",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s017_021052_s011_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "23",
          "submission_status": "AP",
          "submission_status_date": "20031216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21383",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s023_VioxxtmTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26580",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21042slr023ltr.pdf",
              "date": "20031219",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20010110",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "4147",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "41895",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "14237",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20020406",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "21379",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021042_S015_VIOXX.pdf",
              "date": "20080801",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4151",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            },
            {
              "id": "21382",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "4146",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "14236",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            },
            {
              "id": "21374",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21378",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "26577",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "35971",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.htm",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19990520",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "41892",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_52_Vioxx.html",
              "date": "19990520",
              "type": "Review"
            },
            {
              "id": "44089",
              "url": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm",
              "date": "20040930",
              "type": "Other Important Information from FDA"
            },
            {
              "id": "52171",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib DD.pdf",
              "date": "19000101",
              "type": "Pediatric DD Summary Review"
            },
            {
              "id": "52172",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib dd 2.pdf",
              "date": "19000101",
              "type": "Pediatric DD Summary Review"
            },
            {
              "id": "52173",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib CDTL.pdf",
              "date": "19000101",
              "type": "Pediatric CDTL Review"
            },
            {
              "id": "52174",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib_Vioxx-ClinPharmRev-21042s026_21052s019.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "52175",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib clinpharm (2).pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "52176",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib_Vioxx-StatsRev-21042s026_21052s019.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "52177",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021042, 021052_rofecoxib_Vioxx_5-7-01.pdf",
              "date": "19000101",
              "type": "Pediatric Written Request"
            },
            {
              "id": "52178",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021042, 021052_rofecoxib_Vioxx_12-6-01_HFD550_amend.pdf",
              "date": "19000101",
              "type": "Pediatric Amendment 1"
            },
            {
              "id": "52179",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021042, 021052_rofecoxib_Vioxx_5-14-03_HFD550_amend2.pdf",
              "date": "19000101",
              "type": "Pediatric Amendment 2"
            },
            {
              "id": "14235",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21042lbl.pdf",
              "date": "19990520",
              "type": "Label"
            },
            {
              "id": "4145",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/21042ltr.pdf",
              "date": "19990520",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20010613",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "21377",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021042_S011_VIOXX.pdf",
              "date": "20080804",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20000317",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20000225",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "41893",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021042_S001_VIOXX.pdf",
              "date": "20080804",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "28",
          "submission_status": "AP",
          "submission_status_date": "20040914",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21386",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021042_S028_VIOXX.pdf",
              "date": "20080731",
              "type": "Review"
            },
            {
              "id": "26582",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21042s028,21052s021ltr.pdf",
              "date": "20040916",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "26",
          "submission_status": "AP",
          "submission_status_date": "20040819",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "4152",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21052s019,026ltr.pdf",
              "date": "20040825",
              "type": "Letter"
            },
            {
              "id": "52170",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/rofecoxib_Vioxx-MedRev-21042s026_21052s019.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "14241",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021052s026_021042s019lbl.pdf",
              "date": "20040819",
              "type": "Label"
            },
            {
              "id": "21385",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021042_S026_VIOXX.pdf",
              "date": "20080731",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "18",
          "submission_status": "AP",
          "submission_status_date": "20030806",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "4150",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21042se8-018,21052se8-012ltr.pdf",
              "date": "20030815",
              "type": "Letter"
            },
            {
              "id": "14240",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21042se8-018,21052se8-012_vioxx_lbl.pdf",
              "date": "20030815",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "24",
          "submission_status": "AP",
          "submission_status_date": "20031216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21384",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s024_021052_s017_VioxxtmTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26581",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr017,21042slr024ltr.pdf",
              "date": "20031219",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "submission_status": "AP",
          "submission_status_date": "20020625",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "21380",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021042_S016_VIOXX.pdf",
              "date": "20080801",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "22",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41899",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26579",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "35969",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            },
            {
              "id": "21375",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "26575",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "14",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4149",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "41897",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "14239",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "20",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41898",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26578",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20000810",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "4148",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "41896",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "14238",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20000307",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "21373",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021042_S004_VIOXX.pdf",
              "date": "20080804",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21376",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "26576",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "35970",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "19991028",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41894",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_S002_VIOXX.pdf",
              "date": "20080804",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "33",
          "submission_status": "AP",
          "submission_status_date": "20160509",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4153",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021042Orig1s033,021052Orig1s024ltr.pdf",
              "date": "20160511",
              "type": "Letter"
            },
            {
              "id": "14242",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021042s033,021052s024lbl.pdf",
              "date": "20160511",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA021042",
      "sponsor_name": "MERCK",
      "products": [
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "VIOXX",
          "active_ingredients": [
            {
              "name": "ROFECOXIB",
              "strength": "50MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "VIOXX",
          "active_ingredients": [
            {
              "name": "ROFECOXIB",
              "strength": "12.5MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "VIOXX",
          "active_ingredients": [
            {
              "name": "ROFECOXIB",
              "strength": "25MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}